The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice
about
The diagnosis of primary biliary cirrhosisIdentification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisImplications of genome-wide association studies in novel therapeutics in primary biliary cirrhosisDifferential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapyClonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII miceIL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.Extrahepatic autoimmune conditions associated with primary biliary cirrhosis.Women and primary biliary cirrhosis.Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis.Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.Animal models of primary biliary cirrhosis.Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis.Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon CancerSpecific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.New therapeutics in primary biliary cirrhosis: will there ever be light?Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.Gene Therapy for Autoimmune Disease.Toward solving the etiological mystery of primary biliary cholangitis.
P2860
Q26829493-C123489A-24D7-4DD3-81B8-9C1B809A28B7Q28533202-7E33BF40-2658-4F40-8B43-2367737BB0E9Q33579196-1AFA92F6-C0EC-4FE9-B863-AD96FB56C3A5Q34061724-54D71B01-7777-4C30-9DB4-549770C43636Q35619815-6D26B964-4C4C-4380-A458-5ED820062CBEQ36756314-C94A04E5-BDB7-4C1F-B7EB-47DED34E18C5Q36791956-9653B681-76C5-4E97-B720-D9C3664B402CQ37028327-23F1EBD9-5D17-423A-9600-641DBA59FB7EQ37722308-B4BDF5B0-4470-4146-8BC9-C11178232249Q38210250-D178CCE4-145B-4A8F-8648-3654D65EC512Q38252904-3DBF81BC-51D6-4D16-A5B1-EE0EC4434C4AQ39003378-3E43ADA1-F2C8-4817-AB65-002C84FC7B0AQ39792098-92A36443-A775-49D2-94A1-99711910DCF7Q41221983-2AC4CAD4-5A1E-4CF9-BBAD-8E05172EA3DFQ41592947-7EEAA8B8-AF04-4C2A-B887-6A2A292DD5F3Q42327631-AC0F5304-AC9C-49CE-803B-CB70E2015616Q42690764-83BDEFE2-3D68-4622-BFBC-73A9B7BFBEE1Q46182874-B846CED3-5EE6-4C7F-B4A0-056032E4BACEQ46197984-F2B243A5-E4D6-4CA7-9B73-E2CBF18C4BF8Q53014578-4BF16343-5AE2-4CD7-AEF2-811343208449Q55387422-0FA9A949-C7E0-4F3B-BABB-5F259EE221D0
P2860
The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The immunobiology of colitis a ...... tor beta receptor type II mice
@ast
The immunobiology of colitis a ...... tor beta receptor type II mice
@en
type
label
The immunobiology of colitis a ...... tor beta receptor type II mice
@ast
The immunobiology of colitis a ...... tor beta receptor type II mice
@en
prefLabel
The immunobiology of colitis a ...... tor beta receptor type II mice
@ast
The immunobiology of colitis a ...... tor beta receptor type II mice
@en
P2093
P2860
P50
P356
P1433
P1476
The immunobiology of colitis a ...... tor beta receptor type II mice
@en
P2093
Gary L Norman
Guo-Xiang Yang
Kazuhito Kawata
Kazuichi Okazaki
Koichi Tsuneyama
Masanobu Tsuda
Patrick Leung
Takahiko Nakajima
Weici Zhang
William M Ridgway
P2860
P304
P356
10.1002/HEP.25803
P407
P577
2012-10-01T00:00:00Z